Latest Revenue Generation News

Health and Plant Protein Group Limited reported a significantly reduced net loss of $43,000 for the half-year ended December 31, 2024, compared to a $748,000 loss in the prior period, despite no operational revenue following the sale of its macadamia division.

Mighty Kingdom has completed a strategic review, trimming $2.5 million in annual costs without disrupting current contracts and positioning itself for new revenue growth.

Artrya Limited has launched a A$15 million capital raising to fund the development and commercial rollout of its Salix AI-powered coronary artery disease diagnostic platform, targeting the lucrative US healthcare market.

AMP Limited’s FY24 Data Pack outlines a solid underlying profit performance despite headwinds, with key insights into its banking, platform, and wealth management divisions.

Tamboran Resources Corporation posted a $20 million net loss for the half year ending December 31, 2024, reflecting intensified exploration and development activities in the Beetaloo Basin amid no revenue generation. The company’s cash reserves declined to $59.4 million, underscoring the pressing need for additional capital to fund ongoing projects.

Avenira Limited has ended its licensing agreement with Aleees, freeing the company to focus on a phased development of its Wonarah Phosphate Project aimed at early revenue generation in late 2025.

Horizon Minerals has commenced processing the first ore from its Phillips Find Gold Project, marking a key milestone in its path to gold production. The joint venture with BML Ventures is progressing well, with mining operations already delivering substantial volumes.

Mt Malcolm Mines NL has completed bulk sampling at its Golden Crown Prospect, recovering 218 ounces of gold doré from high-grade material and generating over AUD$835,000 in revenue. The company is now advancing resource estimations and planning future mining strategies.

DigitalX Limited has completed the placement of all shortfall shares from its recent rights issue, raising a total of approximately $5.09 million and attracting new supportive shareholders. The company is deploying these funds to expand revenue-generating staking activities within the digital asset space.

Rhythm Biosciences has fast-tracked the integration of the geneType™ business, restoring full commercial capabilities ahead of schedule and setting the stage for expanded market reach.

Calix Limited has successfully closed its Share Purchase Plan, raising $2.1 million to complement a prior $20 million institutional placement, strengthening its balance sheet to advance key environmental technology projects.

Yojee has formed a strategic joint venture with SmartClear to integrate advanced customs technology into its MOSAIC platform, supported by an oversubscribed $3.5 million capital raise aimed at fast-tracking growth in Australia and New Zealand.